Загрузка...
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
‘Old’ colistin and polymyxin B are increasingly used as last-line therapy against multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. For intravenous administration, colistin is dosed as its inactive prodrug colistin methanesulfonate...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477253/ https://ncbi.nlm.nih.gov/pubmed/22959816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diagmicrobio.2012.07.010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|